Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 204S204 trades$51.20M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Perez Garcia Andrea GDirector |  HIMSHims & Hers Health, Inc.Grant or award | A | — 8,223 sh | Aug 14, 2026 |
| 5 | Haas JasonDirector | LGNDLIGAND PHARMACEUTICALS INC Option exercise | M | — 6,138 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 5 | Akerib AvidanVP, Associative Computing |  GSITGSI TECHNOLOGY INCGrant or award | A | — 40.0K sh | Aug 14, 2026 traded Aug 13, 2026 |
| 5 | Carroll Patrick HarrisonChief Medical Officer | HIMSHims & Hers Health, Inc. Grant or award | A | — 260 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 5 | Fukushima RyanCEO, Data |  TEMTempus AI, Inc.Gift | G | — 62.2K sh | Aug 14, 2026 traded Aug 12, 2026 |
| 5 | Autor Deborah M.Director, Chief Policy Officer | HIMSHims & Hers Health, Inc. Grant or award | A | — 8,223 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 5 | Russell Alan JDirector, Chief Scientific Officer |  EWTXEdgewise Therapeutics, Inc.Grant or award | A | — 32.5K sh | Aug 14, 2026 traded Aug 12, 2026 |
| 5 | Russell Alan JDirector, Chief Scientific Officer | EWTXEdgewise Therapeutics, Inc. Grant or award | A | — 65.0K sh | Aug 14, 2026 traded Aug 12, 2026 |
| 4 | Clark KyleDirector, SEE REMARKS |  BETABETA Technologies, Inc.Open-market sale · 10b5-1 plan | SELL | $763K 30.0K sh | Aug 14, 2026 traded Aug 13, 2026 |
| 4 | Clark KyleDirector, SEE REMARKS | BETABETA Technologies, Inc. Open-market sale · 10b5-1 plan | SELL | $352K 15.0K sh | Aug 14, 2026 traded Aug 12, 2026 |
| 2 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | $410K 7,171 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 2 | Chuang Patrick T.Senior VP, Memory Design | GSITGSI TECHNOLOGY INC Grant or award | A | — 40.0K sh | Aug 14, 2026 traded Aug 13, 2026 |
| 1 | McNamara PeterChief Scientific Officer |  TECXTectonic Therapeutic, Inc.Open-market sale · 10b5-1 plan | SELL | $1,505 43 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 1 | Shackley Brian CharlesSVP, Chief Accounting Officer |  AVAVAeroVironment IncOpen-market sale · 10b5-1 plan | SELL | $41K 205 sh | Aug 14, 2026 traded Aug 14, 2026 |
| 1 | Hooker David StevensDirector |  NPBNORTHPOINTE BANCSHARES INCOpen-market sale · 10b5-1 plan | SELL | $421 24 sh | Aug 14, 2026 traded Aug 13, 2026 |
| 1 | Hooker David StevensDirector | NPBNORTHPOINTE BANCSHARES INC Open-market sale · 10b5-1 plan | SELL | $5,943 339 sh | Aug 14, 2026 traded Aug 13, 2026 |
| 0 | McNamara PeterChief Scientific Officer | TECXTectonic Therapeutic, Inc. Option exercise · 10b5-1 plan | M | $633 43 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | Rezvan MitraChief Accounting Officer |  SAILSailPoint, Inc.Open-market sale · 10b5-1 plan | SELL | $24K 1,214 sh | Aug 14, 2026 traded Aug 13, 2026 |
| 0 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | $160K 2,869 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | — 2,869 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 16.1K sh | Aug 14, 2026 traded Aug 13, 2026 |
| 0 | Larson Keith DGeneral Counsel and Secretary |  VGVenture Global, Inc.Option exercise · 10b5-1 plan | M | — 555.6K sh | Aug 14, 2026 traded Aug 13, 2026 |
| 0 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | $145K 2,074 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | Dageville BenoitDirector | SNOWSnowflake Inc. Gift · 10b5-1 plan | G | — 16.7K sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | $230K 3,348 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | — 3,348 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | — 16.2K sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | — 2,074 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | McNamara PeterChief Scientific Officer | TECXTectonic Therapeutic, Inc. Option exercise · 10b5-1 plan | M | — 43 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $168K 16.1K sh | Aug 14, 2026 traded Aug 13, 2026 |
| 0 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | — 7,171 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | Larson Keith DGeneral Counsel and Secretary | VGVenture Global, Inc. Option exercise · 10b5-1 plan | M | $439K 555.6K sh | Aug 14, 2026 traded Aug 13, 2026 |
| 60 | Walsh ColinDirector |  ATTOAttovia Therapeutics, Inc.Open-market purchase | BUY | $1.78M 85.0K sh | Aug 13, 2026 traded Aug 5, 2026 |
| 59 | Clark Stephen SChief People Officer |  AMRZAmrize LtdOpen-market purchase | BUY | $249K 5,260 sh | Aug 13, 2026 traded Aug 11, 2026 |
| 59 | Oran BarisChief Financial Officer | AMRZAmrize Ltd Open-market purchase | BUY | $142K 3,000 sh | Aug 13, 2026 traded Aug 11, 2026 |
| 55 | Oran BarisChief Financial Officer | AMRZAmrize Ltd Open-market purchase | BUY | $141K 3,000 sh | Aug 13, 2026 traded Aug 12, 2026 |
| 52 | Walsh ColinDirector | ATTOAttovia Therapeutics, Inc. Open-market sale | SELL | $1.61M 76.4K sh | Aug 13, 2026 traded Aug 5, 2026 |
| 51 | Binkowski BrentCHIEF OPERATING OFFICER |  CVRXCVRx, Inc.Open-market purchase | BUY | $76K 26.2K sh | Aug 13, 2026 traded Aug 13, 2026 |
| 50 | Harbison Richard GEVP, Refining |  PSXPhillips 66Open-market sale | SELL | $11.66M 52.1K sh | Aug 13, 2026 traded Aug 12, 2026 |
| 49 | Littleton GayleCLO, CCO, CAO & Corp Sec |  HOGHARLEY-DAVIDSON, INC.Open-market purchase | BUY | $198K 7,500 sh | Aug 13, 2026 traded Aug 11, 2026 |